86
Views
9
CrossRef citations to date
0
Altmetric
Case Report

Oral Sumatriptan‐Induced Myocardial Infarction

, M.D.
Pages 309-311 | Received 24 Jul 2003, Accepted 07 Jan 2004, Published online: 16 Aug 2004

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Silvia Barra, Simona Lanero, Alfredo Madrid, Crescenzo Materazzi, Giancarlo Vitagliano, Paul RJ Ames & Giovanni Gaeta. (2010) Sumatriptan therapy for headache and acute myocardial infarction. Expert Opinion on Pharmacotherapy 11:16, pages 2727-2737.
Read now

Articles from other publishers (8)

Lígia N. M. Ribeiro, Gustavo H. Rodrigues da Silva, Verônica M. Couto, Simone R. Castro, Márcia C. Breitkreitz, Carolina S. Martinez, Daniela E. Igartúa, Maria J. Prieto & Eneida de Paula. (2020) Functional Hybrid Nanoemulsions for Sumatriptan Intranasal Delivery. Frontiers in Chemistry 8.
Crossref
Elizabeth Leroux & John Rothrock. (2019) Triptans for Migraine Patients With Vascular Risks: New Insights, New Options. Headache: The Journal of Head and Face Pain 59:9, pages 1589-1596.
Crossref
I. Larivière, A. Garat, P. Nisse & M. Mathieu-Nolf. (2012) Intoxications pédiatriques par les triptans : revue des cas recensés au centre antipoison de Lille (2000–2010). Archives de Pédiatrie 19:3, pages 254-259.
Crossref
Marcus Smith, Harsh Golwala & Pedro Lozano. (2011) Zolmitriptan Induced Acute Coronary Syndrome: A Unique Case. American Journal of Therapeutics 18:5, pages e153-e156.
Crossref
Claudia R Weder & Markus Schneemann. (2009) Triptans and troponin: a case report. Orphanet Journal of Rare Diseases 4:1.
Crossref
Antoinette MaassenVanDenBrink, David Centurión & Carlos M. Villalón. (2008) Crosstalk of vascular 5-HT1 receptors with other receptors: Clinical implications. Neuropharmacology 55:6, pages 986-993.
Crossref
Melissa L Givens & Ellen O’Connell. (2007) Toxicologic issues during cardiopulmonary resuscitation. Current Opinion in Critical Care 13:3, pages 287-293.
Crossref
. (2005) Current awareness: Pharmacoepidemiology and drug safety. Pharmacoepidemiology and Drug Safety 14:2, pages i-xii.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.